latest news

Colorectal cancer is the most common gastrointestinal cancer, and sadly its prevalence is increasing in younger age groups. There is an unmet need for new treatment options for this type of cancer, where surgery, chemotherapy and targeted therapy are the only available treatment options for many patients. With increasing survival rates, less side effects and demand for better quality of life, the role of newer drugs especially immunotherapy in the treatment of colorectal cancer is being extensively evaluated in many countries. To understand how immunotherapy for colorectal cancer works and who can undertake the treatment, we connected with Dr. G. Vamshi, Krishna Reddy, Director-Oncology Services, Consultant Medical Oncologist and Hemato Oncologist, Yashoda hospitals Hyderabad. Here's what he says about this cancer treatment method. What is immunotherapy? Immunotherapy involves use of injections to help the person's own immune system to better recognize and destroy the cancer ...

Colorectal cancer cases among young adults have been increasing over the last two decades, and the Covid pandemic has worsened the plight of patients suffering from this ailment, a leading private healthcare group said on Thursday. According to the doctors, delay in screening when symptoms show up also aggravates these cases, and during the pandemic, many patients' ailments moved into advanced stages as they stayed at home. "The rate of colorectal cancer has been increasing among young adults in their 20s to 40s over the last two decades. This is an age when people are active, building families and careers and it is important to ensure the quality of life for these patients after treatment. What Causes Colorectal Cancer Some of the factors that may raise the risk of Colorectal Cancer are as follows: Age Anybody who is above 50 years old is at higher risk of suffering from colorectal cancer. Diabetes People with diabetes or insulin resistance are at higher risk of suffering...